Central Nervous System Treatment Market Size, Share, Trends & Industry Analysis, By Disease Type (Neurovascular Diseases, Neurodegenerative Diseases, Mental Health, Infectious Diseases, and Others), By Drug Class (Immunomodulatory Drugs, Interferons, Decarboxylase Inhibitors, Dopamine Agonists, Antidepressants, Others) By Drug Type (Biologics and Non-biologics), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies), and Regional Forecast, 2025-2032

Last Updated: November 17, 2025 | Format: PDF | Report ID: FBI103973

To get information on various segments, share your queries with us

ATTRIBUTE	DETAILS
Study Period	2019-2032
Base Year	2024
Estimated Year	2025
Forecast Period	2024-2032
Historical Period	2019-2023
Unit	Value (USD billion)
Segmentation	By Disease Type Neurovascular Diseases Hemorrhagic Stroke Ischemic Stroke Others Neurodegenerative Diseases Alzheimer’s Disease Parkinson’s Disease Multiple Sclerosis Others Mental Health Epilepsy Mood Disorders Anxiety Disorders Others Infectious Diseases Meningitis Encephalitis Others Others
	By Drug Class Immunomodulatory Drugs Interferons Decarboxylase Inhibitors Dopamine Agonists Antidepressants Analgesics Others
	By Drug Type Biologics Non-biologics
	By Distribution Channel Hospital Pharmacies Retail Pharmacies Online Pharmacies
	By Region North America (By Disease Type, By Drug Class, By Drug Type By Distribution Channel, and By Country) U.S. (By Drug Type) Canada (By Drug Type) Europe (By Disease Type, By Drug Class, By Drug Type, By Distribution Channel, and By Country) U.K. (By Drug Type) Germany (By Drug Type) France (By Drug Type) Italy (By Drug Type) Spain (By Drug Type) Rest of Europe (By Drug Type) Asia Pacific (By Disease Type, By Drug Class, By Drug Type, By Distribution Channel, and By Country) China (By Drug Type) Japan (By Drug Type) India (By Drug Type) Australia (By Drug Type) Southeast Asia (By Drug Type) Rest of Asia Pacific (By Drug Type) Latin America (By Disease Type, By Drug Class, By Drug Type, By Distribution Channel, and by Country) Brazil (By Drug Type) Mexico (By Drug Type) Rest of Latin America (By Drug Type) Middle East & Africa (By Disease Type, By Drug Class, By Drug Type, By Distribution Channel, and by Country) GCC (By Drug Type) South Africa (By Drug Type) Rest of Middle East & Africa (By Drug Type)